Skip to main content
Log in

Erfassung von Pruritus – aktuelle Standards und Implikationen für die Praxis

Konsensuspaper der Initiative Pruritusparameter der Arbeitsgemeinschaft Pruritusforschung (AGP)

Assessment of pruritus – current standards and implications for clinical practice

Consensus paper of the Action Group Pruritus Parameter of the International Working Group on Pruritus Research (AGP)

  • Leitthema
  • Published:
Der Hautarzt Aims and scope Submit manuscript

An Erratum to this article was published on 08 September 2012

Zusammenfassung

Mit einer Prävalenz von ca. 20% ist chronischer Pruritus als Symptom vieler Erkrankungen von erheblicher gesundheitsökonomischer Relevanz. Der Mangel an spezifischen Therapien macht die Entwicklung neuer Substanzen und deren Überprüfung in klinischen Studien dringend notwendig. Die objektive Messung der Empfindung Pruritus ist derzeit noch nicht möglich. Aus diesem Grund soll Pruritus anhand eines standardisierten Sets an verschiedenen Instrumenten erfasst werden. Die Intensitätsskalen wie die Visuelle Analog Skala (VAS) werden zur Verlaufsdokumentation am häufigsten genutzt. Zur Erfassung der Pruritusintensität ist die VAS kein optimales, aber bisher noch unverzichtbares Instrument. Die VAS sollten in klinischen Studien in Kombination mit weiteren Skalen verwendet werden, um die Daten intern auf Konsistenz prüfen zu können. Weitere Instrumente zur Intensitäts- und Verlaufsdokumentation sind in Entwicklung. Die Kratzaktivität und kratzassoziierte Läsionen können derzeit hauptsächlich deskriptiv in der Praxis erfasst werden. In Studien wurden Geräte zur Erfassung der Kratzaktivität eingesetzt, allerdings fehlen derzeit noch methodische Studien. Der Patienten-Benefit-Index ist ein unverzichtbares Tool in klinischen Studien. Ein Fragebogen zur Erfassung der Anamnese und einiger pruritusspezifischer Parameter ist bereits entwickelt und publiziert. Fragebögen, die die Lebensqualität, Angst und Depression erfassen, dienen dazu, weitere ökonomisch relevante Parameter der Patienten zu erfassen. Die Erfassung der Lebensqualität liefert z. B. wichtige Hinweise zur Einschätzung des individuellen Leidensdrucks. Die Ergebnisse dieser Fragebögen können mit den Daten der Pruritusintensitätsskalen korreliert werden. Die relevanten Fragebögen können z. T. bereits digital erfasst werden und stehen somit unmittelbar bei der Patientenversorgung zur Verfügung. Weitere methodische Entwicklungen und Studien sind notwendig, um ein robustes Set an Messinstrumenten zur Erhebung von Pruritus in der Praxis und in klinischen Studien zu definieren.

Abstract

With a prevalence of 20%, chronic pruritus is a symptom of many diseases with major impact on healthcare costs. The lack of specific therapeutic measures makes the development of new drugs and their testing in clinical trials urgent. It is not possible to measure pruritus in an objective way. For these reasons, it is necessary to have a series of standardized measures to characterize pruritus in a reliable way. Intensity scales such as the visual analog scale (VAS) are most frequently used to document the course of the symptoms. However, for assessing pruritus intensity, VAS is not an optimal instrument, although it cannot be dispensed with. The VAS should be combined with other scales in clinical studies in order to internally test the consistency of data. Other instruments for assessing intensity and course of pruritus are in the process of development. Presently scratch activity and scratch-associated lesions can be documented in a descriptive fashion. There are some studies that have employed devices to document scratch activity; however, methodological studies are not yet available. The patient-benefit index is an indispensable tool in clinical trials. A questionnaire for gathering data on the history and some pruritus-specific parameters has been developed and published. Questionnaires on patient quality of life, anxiety and depression are helpful in obtaining data on other cost-relevant parameters. A questionnaire on the quality of life, for instance, can provide important help in the assessment of the burden of the disease. The results of these questionnaires can be correlated with data on pruritus intensity scales. The relevant questionnaires have been partially digitalized so that they are available immediately as part of patient care. Additional methodological developments and studies are required in order to define a robust set of instruments for measuring pruritus in daily practice and in clinical studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1

Literatur

  1. Alvarenga TM, Caldeira AP (2009) Quality of life in pediatric patients with atopic dermatitis. J Pediatr (Rio J) 85(5):415–420

    Google Scholar 

  2. Baiardini I, Bousquet PJ, Brzoza Z et al (2010) Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper. Allergy 65(3):290–295

    Article  PubMed  CAS  Google Scholar 

  3. Baiardini I, Pasquali M, Braido F et al (2005) A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). Allergy 60(8):1073–1078

    Article  PubMed  CAS  Google Scholar 

  4. Blome C, Augustin M, Siepmann D et al (2009) Measuring patient-relevant benefits in pruritus treatment: development and validation of a specific outcomes tool. Br J Dermatol 161:1143–1148

    Article  PubMed  CAS  Google Scholar 

  5. Darsow U, Mautner VS, Bromm B et al (1997) Der Eppendorfer Juckreizfragebogen. Hautarzt 48:730–733

    Article  PubMed  CAS  Google Scholar 

  6. Darsow U, Ripphoff E, Ring J (2004) Differences in itch perception between atopic eczema und chronic urticaria. J Allergy Clin Immunol 113 (2):2 96

    Article  Google Scholar 

  7. Darsow U, Scharein E, Simon D et al (2001) New aspects of itch pathophysiology: component analysis of atopic itch using the „Eppendorf itch questionnaire“. Int Arch Allergy Immunol 124:326–331

    Article  PubMed  CAS  Google Scholar 

  8. Desai NS, Poindexter GB, Miller Monthrop Y et al (2008) A pilote quality-of-life instrument for pruritus. J Am Acad Dermatol 259:234–244

    Article  Google Scholar 

  9. Dziuballe P, Forster C et al (2011) The single source architecture x4 T to connect medical documentation and clinical research. Stud Health Technol Inform 169:902–906

    PubMed  Google Scholar 

  10. Ehlers A, Stangier U, Dohn D et al (1993) Kognitive Faktoren beim Juckreiz: Entwicklung und Validierung eines Fragebogens. Verhaltenstherapie 3:112–119

    Article  Google Scholar 

  11. Elman S, Hynan LS, Gabriel V, Mayo MJ (2010) The 5-D-itch scale: a new measure of pruritus. Br J Dermatol 162:587–593

    Article  PubMed  CAS  Google Scholar 

  12. Evers AWM, Duller P, Jong EMGJ de et al (2009) Effectiveness of a brief multidisciplinary itch-coping programme in adults with atopic dermatitis. Acta Derm Venereol 89:57–63

    PubMed  Google Scholar 

  13. Evers AWM, Duller P, Kerkhof PCM van de et al (2008) The impact of chronic skin disease on daily life (ISDL): a generic and dermatology-specific health instrument. Br J Dermatol 158:101–108

    PubMed  CAS  Google Scholar 

  14. Finlay A, Khan G (1994) Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol 19:210–216

    Article  PubMed  CAS  Google Scholar 

  15. Fritz F, Balhorn S, Riek M et al (2012) Qualitative and quantitative evaluation of EHR-integrated mobile patient questionnaires regarding usability and cost-efficiency. Int J Med Inform 81:303–313

    Article  PubMed  Google Scholar 

  16. Fritz F, Phan NQ, Dugas M et al (2011) Correlation of itch intensity with quality of life, anxiety and depression. Acta Derm Venereol 91:636

    Google Scholar 

  17. Fritz F, Ständer S, Breil B et al (2011) CIS-based registration of quality of life in a single source approach. BMC Med Inform Decis Mak 11:26

    Article  PubMed  Google Scholar 

  18. Gandek B, Ware JE, Aaronson NK et al (1998) Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 51:1171–1178

    Article  PubMed  CAS  Google Scholar 

  19. Globe D, Bayliss MS, Harrison DJ (2009) The impact of itch symptoms in psoriasis: results from physician interviews and patient focus groups. Health Qual Life Outcomes 7:62

    Article  PubMed  Google Scholar 

  20. Heitkemper T, Hofmann T, Phan NQ et al (2010) Aquagenic pruritus: associated diseases and clinical pruritus characteristics. J Dtsch Dermatol Ges 8:797–804

    PubMed  Google Scholar 

  21. Herrmann C (1997) International experiences with the hospital anxiety and depression scale – a review of validation data and clinical results. J Psychosom Res 42:17–41

    Article  PubMed  CAS  Google Scholar 

  22. Herrmann C, Buss U, Snaith RP (1995) HADS-D. Hospital Anxiety and Depression Scale-Deutsche Version. Ein Fragebogen zur Erfassung von Angst und Depressivität in der somatischen Medizin. Huber, Bern

  23. Kupfer J, Keins P, Brosig B et al (2003) Development of questionnaires on coping with diseases and itching cognitions for children and adolescents with atopic eczema. Dermatol Psychosom 4:79–85

    Article  Google Scholar 

  24. Lundqvist C, Benth JS, Grande RB et al (2009) A vertical VAS is a valid instrument for monitoring headache pain intensity. Cephalalgia 29:1034–1041

    Article  PubMed  CAS  Google Scholar 

  25. Mathur VS, Lindberg J, Germain M et al (2010) A longitudinal study of uremic pruritus in hemodialysis patients. Clin J Am Soc Nephrol 5:1410–1419

    Article  PubMed  Google Scholar 

  26. Matterne U, Apfelbacher CJ, Loerbroks A et al (2011) Prevalence, correlates and characteristics of chronic pruritus: a population-based cross-sectional study. Acta Derm Venereol 91:674–679

    PubMed  Google Scholar 

  27. Phan NQ, Blome C, Fritz F et al (2011) Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus. Acta Derm Venereol [Epub ahead of print]

  28. Picardi A, Abeni D, Melchi CF et al (2000) Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 143:983–991

    Article  PubMed  CAS  Google Scholar 

  29. Raap U, Ständer S, Metz M (2011) Pathophysiology of itch and new treatments. Curr Opin Allergy Clin Immunol 11:420–427

    Article  PubMed  CAS  Google Scholar 

  30. Reich A, Heisig M, Phan NQ et al (2011) Visual analogue scale: evaluation of the instrument for the assessment of pruritus. Acta Derm Venereol [Epub ahead of print]

  31. Reich A, Hrehorów E, Szepietowski JC (2010). Pruritus is an important factor negatively influencing the well-being of psoriatic patients. Acta Derm Venereol 90:257–263

    PubMed  Google Scholar 

  32. Schneider G, Driesch G, Heuft G et al (2006) Psychosomatic cofactors and psychiatric comorbidity in patients with chronic itch. Clin Exp Dermatol 31:762–767

    Article  PubMed  CAS  Google Scholar 

  33. Ständer S, Schäfer I, Phan NQ et al (2010) Prevalence of chronic pruritus in Germany: results of a cross-sectional study in a sample working population of 11,730. Dermatology 221:229–335

    Article  PubMed  Google Scholar 

  34. Ständer S, Weisshaar E, Mettang T et al (2007) Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol 87:291–294

    Article  PubMed  Google Scholar 

  35. Ständer S, Streit M, Darsow U et al (2006) Leitlinie: Diagnostisches und therapeutisches Vorgehen bei chronischem Pruritus. J Dtsch Dermatol Ges 4:350–370

    Article  PubMed  Google Scholar 

  36. Szepietowski JC, Reich A, Wiśnicka B (2002) Itching in patients suffering from psoriasis. Acta Dermatovenerol Croat 10:221–226

    PubMed  Google Scholar 

  37. Tessari G, Dalle Vedove C, Loschiavo C et al (2009) The impact of pruritus on the quality of life of patients undergoing dialysis: a single centre cohort study. J Nephrol 22:241–248

    PubMed  CAS  Google Scholar 

  38. Van Os-Medendorp H, Guikers CL, Eland-de Kok PC et al (2008) Costs and cost-effectiveness of the nursing programme „Coping with itch“ for patients with chronic pruritic skin disease. Br J Dermatol 158:1013–1021

    Article  Google Scholar 

  39. Verhoeven EWM, Kraaimaat FW, Jong EMGJ de et al (2009) Individual differences in the effect of daily stressors on psoriasis: a prospective study. Br J Dermatol 161:295–299

    Article  PubMed  CAS  Google Scholar 

  40. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483

    Article  PubMed  Google Scholar 

  41. Weisshaar E, Ständer S, Gieler U et al (2011) Entwicklung eines deutschsprachigen Fragebogens zur Erfassung von chronischem Pruritus (AGP-Fragebogen): Hintergrund und erste Ergebnisse. Hautarzt 62:914–927

    Article  PubMed  CAS  Google Scholar 

  42. Weisshaar E, Apfelbacher CJ, Jäger G et al (2006) Pruritus as a leading symptom: clinical characteristics and quality of life in German and Ugandan patients. Br J Dermatol 155:957–964

    Article  PubMed  CAS  Google Scholar 

  43. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt für sich und seine Koautoren an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Ständer.

Additional information

___Teilnehmer der Initiative Pruritusparameter der AGP___

M. Augustin, Hamburg, C. Blome, Hamburg, U. Darsow, München, M. Dugas, Münster, A. Evers, Nijmegen, C. Foster, Erlangen, R. Fölster-Holst, Kiel, F. Fritz, Münster, U. Gieler, Gießen, A. Kremer, Erlangen, U. Matterne, Heidelberg, T. Mettang, Wiesbaden, M. Metz, Berlin, G. Neufang, Hamburg, N.Q. Phan, Münster, U. Raap, Hannover, A. Reich, Wroclaw, G. Schneider, Münster, S. Steinke, Münster, S. Ständer, Münster, P. Staubach-Renz, Mainz, E. Weisshaar, Heidelberg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ständer, S., Blome, C., Breil, B. et al. Erfassung von Pruritus – aktuelle Standards und Implikationen für die Praxis. Hautarzt 63, 521–531 (2012). https://doi.org/10.1007/s00105-011-2318-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-011-2318-3

Schlüsselwörter

Keywords

Navigation